Jinhe Biotech: Announcement on Application for Issuance of Stocks to Specific Targets under Simple Procedures Accepted by Shenzhen Stock Exchange
Securities code: 002688 Securities abbreviation: Jinhe Biotechnology Announcement number: 2026-066
Jinhe Biotechnology Co., Ltd.
Regarding the application for issuance of stocks to specific objects through simplified procedures
Announcement of acceptance by Shenzhen Stock Exchange
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete, and assume responsibility for any false records, misleading statements or major omissions in the announcement.
Jinhe Biotechnology Co., Ltd. (hereinafter referred to as the "Company") received the "Notice on Acceptance of Application Documents for the Issuance of Stocks by Jinhe Biotechnology Co., Ltd. to Specific Targets" issued by the Shenzhen Stock Exchange (hereinafter referred to as the "Shenzhen Stock Exchange") on July 23, 2026 (Shenzhen Stock Exchange [2026] No. 232). The Shenzhen Stock Exchange checked the application documents submitted by the company for issuance of shares to specific objects through a simplified procedure, and deemed that the application documents were complete and decided to accept the application.
The company's issuance of shares to specific targets through a simplified procedure needs to be reviewed by the Shenzhen Stock Exchange and approved by the China Securities Regulatory Commission (hereinafter referred to as the "China Securities Regulatory Commission") before it can be implemented. There is still uncertainty as to whether it can ultimately pass the review by the Shenzhen Stock Exchange and obtain approval for registration from the China Securities Regulatory Commission and the specific time. The company will fulfill its information disclosure obligations in a timely manner based on the progress of the matter. Investors are advised to pay attention to investment risks. Announcement is hereby made.
Board of Directors of Jinhe Biotechnology Co., Ltd.
July 24, 2026